EIT Health Germany – Mid-term Review Training

Register now for ONE-DAY FACE2FACE MID-TERM REVIEW TRAINING on the 17th and 18th June 2019 9:00am-5:30pm (CEST) at Marsilius Arkaden of Heidelberg University.

The goal of our Mid-term Review Training is to prepare BP2019 projects/activities led by partners of the German CLC for their Mid-term Reviews, which are a focal point in EIT Health’s monitoring process and play a decisive role for the continuation of EIT funding.

During our Mid-term Review Training, we will work on the content and the style of the presentation and the Q&A session. Therefore, participants should bring a slide deck which is ready for a first dry run presentation. In addition to the expertise of the CLC team, you will benefit from the input of an experienced pitch coach. The Mid-term Review Training is a one-day training. Partners can choose freely between 17th and 18th June 2019.

AGENDA: 17th and 18th June 2019

09:00 – 09:30 Welcome & Introduction round:

Each participant/project gives a 1-minute Pitch

09:30 – 10:00 BP2019 Mid-term Reviews:

What to expect and how to prepare (Eva-Maria Markutzik)

10:00 – 10:45 Pitch presentations: How to design a compelling pitch (tba)
10:45 – 11:00 Coffee Break
11:00 – 12:15 Parallel sessions:

(1) Half the teams give a 10-minute pitch with slides, receive feedback from the pitch coach and all participants. Identify areas to expand upon, for final 20-minute pitch.

(2) The other half meet with the CLC team to write and practice Q+As

12:15 – 13:15 Lunch break
13:15 – 14:45 Parallel sessions continue: Teams switch to the other coach(es)
14:45 – 15:00 Coffee Break
15:00 – 16:00 Team work: Time to refine slides and prepare answers for the Q&A session; individual support by the pitch coach and the team of EIT Health Germany
16:00 – 17:30 Final Pitch for all teams with slides and feedback

The Mid-term Review Training targets the requirements provided by EIT Health headquarters:

PURPOSE OF MID-TERM REVIEWS

The goal of the Mid-term Reviews is to discuss activity progress to date, review the amendments that were submitted as part of the BP amendment, check if support is needed, and project the course of action until year-end. For activities that continue in 2020, the evaluators will be looking at your plans for the next year.

EVALUATION PROCESS

Participation in the Mid-term Review of the project’s leader, as well as the main partners within the activity, will be mandatory and will follow the below principles: face-to-face meeting with external reviewers.

Mid-term Review must be considered a Go/No-Go stage gate. A scorecard will guide the process, and independent evaluators will propose a concerted approach to the Director of Innovation.

Three possible outcomes will be then considered:

  • Continue the project.
  • Continue the project with some necessary amendments.
  • Stop the project and the funding.

MID-TERM REVIEW DURATION

The hearing itself will be for a maximum of 65 minutes:

  • 20 minutes maximum for a presentation
  • 45 minutes for an open question and answer session by the Evaluation Board.

FEEDBACK BY EVALUATORS

As a result of the meeting evaluators will produce the feedback report for each activity with recommendations and a conclusion:

  1. Green– continue activity as planned
  2. Yellow– make changes to some parts of the activity to ensure its success and impact
  3. Red– stop the activity due to the underperformance.

The feedback will also focus on activity’s future plans and sustainability.

Back to top
Image of

Close